Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
Condition(s):Lupus Erythematosus, SystemicLast Updated:August 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Lupus Erythematosus, SystemicLast Updated:August 7, 2023Recruiting
Condition(s):Eating DisorderLast Updated:April 27, 2018Unknown status
Condition(s):Lung Cancer; ImmunotherapyLast Updated:May 4, 2020Unknown status
Condition(s):Lung CancerLast Updated:January 2, 2020Unknown status
Condition(s):Systemic Lupus ErythematosusLast Updated:February 24, 2022Unknown status
Condition(s):SARS-CoV 2 Infection; Covid19Last Updated:March 21, 2022Completed
Condition(s):Idiopathic Pulmonary Fibrosis, Acute Fatal FormLast Updated:August 8, 2023Recruiting
Condition(s):Autoimmune Polyglandular Syndrome Type I; Autoimmune KeratitisLast Updated:May 5, 2020Completed
Condition(s):Churg-Strauss Syndrome; Eosinophilic Asthma; Eosinophilic Esophagitis; Eosinophilic PneumoniaLast Updated:December 17, 2020Unknown status
Condition(s):Type1diabetesLast Updated:March 27, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.